Peer-influenced content. Sources you trust. No registration required. This is HCN.
Oncology News Central (ONC)
MacroGenics’ Phase II TAMARACK trial for vobramitamab duocarmazine in metastatic prostate cancer reported five patient deaths, raising critical safety concerns but also highlighting promising response rates that could influence future treatment protocols.
Oncology, Medical June 4th 2024
Interim results from J&J’s Phase I study of JNJ-6420 highlight both promising efficacy in prostate cancer treatment and serious safety concerns, with 60% of patients experiencing severe adverse events.
Oncology, Medical June 3rd 2024
MDLinx
Balancing sodium intake is crucial for sleep health, with both excessive and deficient levels leading to disturbances. Tailored recommendations based on individual activity levels can help maintain optimal sodium balance and support sleep quality.
All Specialties May 20th 2024
Annals of Internal Medicine
Lower baseline testosterone and hormonal imbalances, including low SHBG and DHT levels, are significantly associated with increased all-cause and cardiovascular mortality in aging men.
Cardiology May 20th 2024
MD Newsline
A large-scale randomized controlled trial has identified significant prognostic factors for overall survival (OS) and cancer-specific survival (CSS) in localized prostate cancer, offering new insights into optimizing treatment strategies using surgery and radiotherapy.
Oncology, Medical May 20th 2024
Healthgrades for Professionals
The Medscape Women Physicians Report 2020 reveals that 64% of female physicians prioritize work-life balance, often feeling conflicted between their careers and caregiving responsibilities, necessitating flexible work arrangements and supportive policies.
Allergy & Immunology May 20th 2024